FundedIQ
Biotechnology

Mirai Bio: Funding, Investors & Team (Sep 2026)

Mirai Bio has created an open platform that utilizes AI to overcome the primary challenges in manufacturing and advance the future of genetic medicine.

www.miraibio.com LinkedIn Cambridge, United States 11-50 employees
Biopharma Biotechnology Pharmaceutical B2B
Total raised
$50.0M
Rounds
1
Latest
Series A
Sep 2024

Mirai Bio has raised $50.0M across 1 funding round on record, the most recent a Series A of $50.0M announced in Sep 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Mirai Bio Company Profile and Key Stats

Total funding raised
$50.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$50.0M in Sep 2024
Employees
11-50
reported band
Headquarters
Cambridge, United States

Latest funding round on record: Sep 2024.

Mirai Bio Funding Rounds

Date
Round
Amount
Series A
$50.0M

Mirai Bio Founders and Leadership Team

Name
Role
Contact
Geoffrey Von Maltzahn
Founder

No contact details are on record for this team yet.

Mirai Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
8,378
$15M

Mirai Bio's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Mirai Bio in Biotechnology and Cambridge

Companies Similar to Mirai Bio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Mirai Bio Funding FAQs

What does Mirai Bio do?

Mirai Bio has created an open platform that utilizes AI to overcome the primary challenges in manufacturing and advance the future of genetic medicine.

How much funding has Mirai Bio raised?

Mirai Bio has raised $50.0M across 1 round on record. The most recent is a Series A of $50.0M announced in Sep 2024.

When did Mirai Bio last raise funding?

Mirai Bio's most recent funding round on record is a Series A of $50.0M, announced in Sep 2024.

Who founded Mirai Bio?

FundedIQ lists Geoffrey Von Maltzahn (Founder) at Mirai Bio.

Where is Mirai Bio headquartered?

Mirai Bio is based in Cambridge, Massachusetts, United States.

How many employees does Mirai Bio have?

Mirai Bio is in the 11-50 employee band.

How does Mirai Bio's funding compare to other Biotechnology startups?

Mirai Bio's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Mirai Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mirai Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.